WESSON BRUCE F

Director at MEDASSETS INC · on record since Dec 19, 2007
10% owner at MEDASSETS INC · on record since Dec 19, 2007
Director at Chemtura CORP · on record since Jan 26, 2006
Director at ENCORE MEDICAL CORP · on record since May 22, 2006
Director at QMED INC · on record since Sep 20, 2006
10% owner at ENCORE MEDICAL CORP · on record since Aug 2, 2006
Director Emeritus at ACURA PHARMACEUTICALS, INC · on record since Jan 2, 2024
Director at DERMA SCIENCES, INC. · on record since May 11, 2007
Director at ACURA PHARMACEUTICALS, INC · on record since Jan 28, 2008
10% owner at SPECIALIZED HEALTH PRODUCTS INTERNATIONAL INC · on record since Jun 10, 2008
10% owner at DERMA SCIENCES, INC. · on record since Dec 17, 2009
Director at CAPITAL TRUST INC · on record since Jan 21, 2004
Director at DAOU SYSTEMS INC · on record since Oct 28, 2004
Former Director at DERMA SCIENCES, INC. · on record since Jun 2, 2016
See footnote (1) at ESSENTIAL GROUP INC · on record since Feb 18, 2005

Insider trading activity of WESSON BRUCE F

Transactions on record: 312; since Nov 14, 2003

Open-market buys: 37; $651K

Open-market sells: 139; $34.1M

Companies traded: 8; last filing Jan 2, 2024

Figures computed from official regulatory filings — methodology.

Companies where WESSON BRUCE F has traded

ACURA PHARMACEUTICALS, INC58 tx · $169.5K · Jan 2, 2024
DERMA SCIENCES, INC.23 tx · $2.6M · Jun 2, 2016
MEDASSETS INC158 tx · $31.9M · Jan 27, 2016
Chemtura CORP9 tx · $225K · Mar 4, 2008
QMED INC3 tx · Apr 30, 2007
ENCORE MEDICAL CORP46 tx · $1.4M · Nov 6, 2006
SPECIALIZED HEALTH PRODUCTS INTERNATIONAL INC9 tx · Dec 1, 2005
CAPITAL TRUST INC6 tx · Jan 28, 2005

Track record of WESSON BRUCE F

Statistical track record

Free

Open-market buys: 43

Last buy: Dec 14, 2017

Win rates and median returns are available with a free account (5 insiders/month).

Create a free account

Transaction history of WESSON BRUCE F

Co-insiders of WESSON BRUCE F

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
ACURA PHARMACEUTICALS, INC	Jan 2, 2024	ExerciseD	-37,500	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 2, 2024	Exercise	37,500	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 2, 2024	OtherD	-12,500	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 5, 2023	ExerciseD	-66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 5, 2023	Exercise	66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 5, 2023	AwardD	-50,000	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 11, 2022	ExerciseD	-66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 11, 2022	Exercise	66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 11, 2022	AwardD	-66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	May 28, 2021	AwardD	66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 6, 2021	Exercise	54,790	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 6, 2021	ExerciseD	-54,790	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 6, 2020	Exercise	83,333	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 6, 2020	AwardD	54,790	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 6, 2020	ExerciseD	-83,333	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 8, 2019	AwardD	83,333	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 8, 2019	Exercise	66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 8, 2019	ExerciseD	-66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 3, 2018	Exercise	59,523	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 3, 2018	ExerciseD	-59,523	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 3, 2018	AwardD	66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Dec 15, 2017	Buy	335,734	0.10 USD	$33.6K	SEC
ACURA PHARMACEUTICALS, INC	Jan 5, 2017	Exercise	22,026	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 5, 2017	AwardD	59,523	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 5, 2017	ExerciseD	-22,026	—	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
ACURA PHARMACEUTICALS, INC	Jan 2, 2024	ExerciseD	-37,500	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 2, 2024	Exercise	37,500	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 2, 2024	OtherD	-12,500	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 5, 2023	ExerciseD	-66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 5, 2023	Exercise	66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 5, 2023	AwardD	-50,000	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 11, 2022	ExerciseD	-66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 11, 2022	Exercise	66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 11, 2022	AwardD	-66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	May 28, 2021	AwardD	66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 6, 2021	Exercise	54,790	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 6, 2021	ExerciseD	-54,790	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 6, 2020	Exercise	83,333	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 6, 2020	AwardD	54,790	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 6, 2020	ExerciseD	-83,333	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 8, 2019	AwardD	83,333	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 8, 2019	Exercise	66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 8, 2019	ExerciseD	-66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 3, 2018	Exercise	59,523	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 3, 2018	ExerciseD	-59,523	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 3, 2018	AwardD	66,666	—	—	SEC
ACURA PHARMACEUTICALS, INC	Dec 15, 2017	Buy	335,734	0.10 USD	$33.6K	SEC
ACURA PHARMACEUTICALS, INC	Jan 5, 2017	Exercise	22,026	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 5, 2017	AwardD	59,523	—	—	SEC
ACURA PHARMACEUTICALS, INC	Jan 5, 2017	ExerciseD	-22,026	—	—	SEC